Sara spearheads Motley Rice’s litigation for victims who suffered pancreatic cancer, intestinal blockages, stomach paralysis and other ailments after taking Ozempic® or Wegovy® for weight loss. As part of this litigation, Sara filed the first complaint in the nation alleging harms caused by Wegovy and strongly believes in holding companies accountable for products that target and harm women.
This litigation builds upon Sara’s work on other litigations that have caused harm to women. This includes representing women who suffered devastating effects caused by medical products including Essure® permanent birth control and transvaginal mesh. Sara’s extensive work with experts in Essure provided the foundation for her current service on the Science & Expert Committees for the Hair Relaxer MDL and Social Media MDL , of which Motley Rice holds leadership positions. She also serves on the Plaintiffs Steering Committee overseeing litigation filed in the District of New Jersey for women who developed BIA-ALCL, a rare form of non-Hodgkin’s lymphoma, allegedly caused by textured Allergan breast implants.
As a member of nearly a dozen Motley Rice trial teams, she also helped achieve multiple plaintiff verdicts for tobacco victims and a multi-million verdict for victims of toxic lead paint exposure.*
